Company: SMNR
Filing Date: 2025-07-28
Form Type: 425
Source: 0001213900-25-068268
Chunk: 5

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-28
Form: 425
Chunk 5
---
 (embedded within the Inline XBRL document).                                                                                                                                                                                                                              |

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: July 28, 2025 | DENALI CAPITAL ACQUISITION CORP. 
 By:                              | /s/ Lei Huang           |
|:--------------------|:---------------------------------|:------------------------|
|                     | Name:                            | Lei Huang               |
|                     | Title:                           | Chief Executive Officer |